Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis

NCT04882683 is registered in ClinicalTrials.gov with Shandong Qilu Stem Cells Engineering Co., Ltd. as lead sponsor.

NCT NCT04882683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04882683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis
Lead sponsor
Shandong Qilu Stem Cells Engineering Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2021
Completion date
December 31, 2022
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis